Effects of octreotide on glycaemic control, glucose disposal, hepatic glucose production and counterregulatory hormones secretion in type 1 and type 2 insulin treated diabetic patients-Reference-Cited by-同舟云学术

Effects of octreotide on glycaemic control, glucose disposal, hepatic glucose production and counterregulatory hormones secretion in type 1 and type 2 insulin treated diabetic patients

Published:1997-11 Issue:2 Volume:38 Page:81-89
ISSN:0168-8227
Container-title:Diabetes Research and Clinical Practice
language:en
Short-container-title:Diabetes Research and Clinical Practice

Author:

Lunetta M,Di Mauro M,Le Moli R,Nicoletti F

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference27 articles.

1. SMS 201-995: a very potent and selective octapeptide analogue of somatostatin with prolonged action;Bauer;Life Sci.,1982

2. Effect of a long-acting somatostatin derivative SMS 201-995 (Sandostatin) on glucose homeostasis in type 1 diabetes mellitus;Navascuez;Horm. Res.,1988

3. Somatostatin analog SMS 201-995 and insulin needs in insulin-dependent diabetic patients studied by means of an artificial pancreas;Serrano-Rios;J. Clin. Endocrinol. Metab.,1986

4. Effects of a somatostatin derivative (SMS 201-995) on postprandial hyperglycemia in insulin-dependent diabetics studied by means of a closed-loop device;Nosari;J. Endocrinol. Invest.,1989

5. Somatostatin analogue SMS 201-995 in type 1 diabetes mellitus. Initial experience after repeated administration;Plewe;Scand. J. Gastroenterol.,1986

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peptides in the regulation of glucagon secretion;Peptides;2022-02

2. Endokrines System und Immunmodulation;Arzneimitteltherapie in der Palliativmedizin;2022

3. Endokrines System und Immunmodulation;Arzneimitteltherapie in der Palliativmedizin;2018

4. Effects of anti-somatostatin agents on glucose metabolism;Diabetes & Metabolism;2017-10

5. Diabetic ketoacidosis in a patient with acromegaly and central diabetes insipidus treated with octreotide long-acting release;Diabetology International;2016-12-10